Stay updated on MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.

Latest updates to the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe screenshots show the same study record with no core information changes; only formatting/layout variations are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedAdded new operating-status notices, 18 new Local Institution entries, and a 2025-09 update with revision v3.2.0; removed numerous previously listed sites and detailed contacts, including several locations marked as Recruiting or Withdrawn. Overall: more updated status and expanded/altered site list, with several sites removed.SummaryDifference21%

- Check40 days agoChange DetectedAdded numerous phone numbers, a medical term (Colonic Neoplasms), and a software revision tag v3.1.0; removed the older revision tag v3.0.2.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, and the 'Back to Top' element has been removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has added significant information regarding colorectal cancer and related diseases, including specific drug information for Adagrasib, while removing some location details and references to lung cancer.SummaryDifference3%

Stay in the know with updates to MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.